Isoniazid-Resistant Tuberculosis - A Series of Clinical Cases

1 Global Tuberculosis Report 2022. World Health Organization, 2022. Search in Google Scholar

2 The End TB Strategy. World Health Organization; 2014. http://www.who.int/tb/strategy/end-tb/en/. Accessed March 14, 2019. Search in Google Scholar

3 National Guideline for the Management of Drug-resistant Tuberculosis Cases 2020. Romanian Society of Pneumology 2020. Official Gazette no. 917 bis 2020.10.8 Search in Google Scholar

4 Paul Ioan Stoicescu et al. Management of Multidrug Resistant Tuberculosis Cases. Ministry of Health, "Marius Nasta" Institute of Pneumology, National Tuberculosis Control Program; 2005 Search in Google Scholar

5 Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. World Health Organization; 2014 Search in Google Scholar

6 Arghir OC, Chiotan DI, Cioran NV, et al. Methodological Guideline for the implementation of the National Program for the Prevention, Surveillance and Control of Tuberculosis. Ministry of Health, "Marius Nasta" Institute of Pneumology, National Tuberculosis Control Program; 2015 Search in Google Scholar

7 Daniela Homorodean, Adriana Moisoiu. National Guideline for the TB Laboratory Network. Ministry of Health, "Marius Nasta" Institute of Pneumology, National Tuberculosis Prevention, Surveillance and Control Program; 2017 Search in Google Scholar

8 WHO Treatment Guidelines for Isoniazid-Resistant Tuberculosis: Supplement to the WHO Treatment Guidelines for Drug-Resistant Tuberculosis. World Health Organization; 2018 Search in Google Scholar

9 Ahuja SD, Ashkin D, Avendano M, et al. 'Aultidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Ir/hvidual Patient Data Meta-analysis of 9,153 Patients. PLOS Med. 2012; 9(8):e 1001300 Search in Google Scholar

10 Fox GJ, Mitnick CD, Benedetti A et al. Surgery as an adjunctive treatment for multidrug-resistant tuberculosis: an individual patient data metaanalysis. Clin Infect Dis. 20l6; 62(7):887-895 Search in Google Scholar

11 Harris RC, Khan MS, Martin LJ, et al. The effect of surgety on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2016; 16:262 Search in Google Scholar

12 Seifert M, Catanzaro D, Catanzaro A, Rodwell TC. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PLoS One. 2015 Mar 23;10(3):e0119628. doi: 10.1371/journal.pone.0119628. PMID: 25799046; PMCID: PMC4370653. Search in Google Scholar

13 World Health Organization. Global Tuberculosis Report. Geneva, Switzerland; WHO press; 2013. Search in Google Scholar

14 World Health Organization; Multidrug and Extensively Drug-Resistant TB 2010 Global Report of Surveillance and Response. Geneva, Switzerland; WHO press; 2010. Search in Google Scholar

15 Sougakoff W. Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis. Clin Microbiol Infect. 2011; 17: 800–805. 10.1111/j.1469-0691.2011.03577.x Search in Google Scholar

16 Erdenegerel Narmandakh, Oyuntuya Tumenbayar, Tsetsegtuya Borolzoi, Baasansuren Erkhembayar, Tsolmon Boldoo, Naranzul Dambaa, Buyankhishig Burneebaatar, Naranbat Nymadawa, Satoshi Mitarai, Sarantuya Jav, Chen-Yuan Chiang. Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia. ASM Journals, Antimicrobial Agents and Chemotherapy Vol. 64, No. 7. https://doi.org/10.1128/aac.00537-20 Search in Google Scholar

17 Jindani A, Aber VR, Edwards EA, Mitchison DA. 1980. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis 121:939–949. Search in Google Scholar

18 Zhang Y, Heym B, Allen B, Young D, Cole S. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591–593. Search in Google Scholar

19 Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, Collins D, de Lisle G, Jacobs WR, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227–230. Search in Google Scholar

20 Vilchèze C, Jacobs WR. 2014. Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities. Microbiol Spectr 2:MGM2. Search in Google Scholar

21 Lempens P, Meehan CJ, Vandelannoote K, Fissette K, de Rijk P, Van Deun A, Rigouts L, de Jong BC. Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations. Sci Rep. 2018 Feb 19; 8(1):3246. doi: 10.1038/s41598-018-21378-x. PMID: 29459669; PMCID: PMC5818527. Search in Google Scholar

22 Vilcheze C, Jacobs WR., Jr. Resistance to isoniazid and ethionamide in mycobacterium tuberculosis: genes, mutations, and causalities. Microbiology Spectrum. 2014;2:MGM2-0014-2013. doi: 10.1128/microbiolspec.MGM2-0014-2013. Search in Google Scholar

23 Seifert M, Catanzaro D, Catanzaro A, Rodwell TC. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PloS one. 2015;10:e0119628. doi: 10.1371/journal.pone.0119628. Search in Google Scholar

24 Böttger, E. C. In Antituberculosis Chemotherapy Vol. 40 (eds P. R. Donald & P. D. van Helden) Ch. 14, 128–144 (Karger, 2011). Search in Google Scholar

25 Huyen MN, et al. Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes. Antimicrobial agents and chemotherapy. 2013;57:3620–3627. doi: 10.1128/AAC.00077-13. Search in Google Scholar

26 Ramaswamy SV, et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy. 2003;47:1241–1250. doi: 10.1128/AAC.47.4.1241-1250.2003. Search in Google Scholar

27 Jagielski T, et al. Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates. Pneumonologia i alergologia polska. 2013;81:298–307. Search in Google Scholar